EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC 4.0

Stereotactic radiosurgery and radiotherapy for brainstem metastases: An international multicenter analysis

Felix Ehret iD, Daniel Rueß, Oliver Blanck, Susanne Fichte, Georgios Chatzikonstantinou, Robert Wolff, Lucas Mose, Stephan Mose, Thomas Fortmann, Ralph Lehrke, Menekse Turna, Hale Basak Caglar und 6 weitere

International Journal of Cancer · 2024

DOI: 10.1002/ijc.34980 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift International Journal of Cancer, 2024. Verfasst von Felix Ehret und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berl…. Hauptthemen laut MEDLINE: Radiosurgery, Brain Stem Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Brainstem metastases (BSM) present a significant neuro‐oncological challenge, resulting in profound neurological deficits and poor survival outcomes. Stereotactic radiosurgery (SRS) and fractionated stereotactic radiotherapy (FSRT) offer promising therapeutic avenues for BSM despite their precarious location. This international multicenter study investigates the efficacy and safety of SRS and FSRT in 136 patients with 144 BSM treated at nine institutions from 2005 to 2022. The median radiographic and clinical follow‐up periods were 6.8 and 9.4 months, respectively. Predominantly, patients with BSM were managed with SRS (69.4%). The median prescription dose and isodose line for SRS were 18 Gy and 65%, respectively, while for FSRT, the median prescription dose was 21 Gy with a median isodose line of 70%. The 12‐, 24‐, and 36‐month local control (LC) rates were 82.9%, 71.4%, and 61.2%, respectively. Corresponding overall survival rates at these time points were 61.1%, 34.7%, and 19.3%. In the multivariable Cox regression analysis for LC, only the minimum biologically effective dose was significantly associated with LC, favoring higher doses for improved control (in Gy, hazard ratio [HR]: 0.86, p < .01). Regarding overall survival, good performance status (Karnofsky performance status, ≥90%; HR: 0.43, p < .01) and prior whole brain radiotherapy (HR: 2.52, p < .01) emerged as associated factors. In 14 BSM (9.7%), treatment‐related adverse events were noted, with a total of five (3.4%) radiation necrosis. SRS and FSRT for BSM exhibit efficacy and safety, making them suitable treatment options for affected patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RadiosurgeryBrain Stem NeoplasmsHumansMaleFemaleMiddle AgedAgedAdultAged, 80 and overDose Fractionation, RadiationTreatment OutcomeRetrospective StudiesSurvival RateFollow-Up Studies

Stichwörter der Autor:innen

brain metastasisbrainstemfractionated stereotactic radiotherapyradiosurgerystereotactic radiosurgery

Autor:innen und Institutionen

  • Department of Radiation Oncology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • German Cancer Consortium (DKTK), partner site Berlin, a partnership between DKFZ and Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • European Radiosurgery Center Munich, Munich, Germany.
  • Department of Stereotactic and Functional Neurosurgery, Centre of Neurosurgery, University Hospital Cologne, Cologne, Germany.
  • Department of Radiation Oncology, University Hospital Schleswig-Holstein and Saphir Radiosurgery Center Northern Germany, Kiel, Germany.
  • CyberKnife Center Mitteldeutschland, Erfurt, Germany.

ORCID-Profile: Felix Ehret

Zitieren

APA

Ehret, F., Rueß, D., Blanck, O., Fichte, S., Chatzikonstantinou, G., Wolff, R., Mose, L., Mose, S., Fortmann, T., Lehrke, R., Turna, M., Caglar, H. B., Mortasawi, F., Bleif, M., Krug, D., Ruge, M. I., Fürweger, C., & Muacevic, A. (2024). Stereotactic radiosurgery and radiotherapy for brainstem metastases: An international multicenter analysis. International Journal of Cancer. https://doi.org/10.1002/ijc.34980

Vancouver

Ehret F, Rueß D, Blanck O, Fichte S, Chatzikonstantinou G, Wolff R, et al. Stereotactic radiosurgery and radiotherapy for brainstem metastases: An international multicenter analysis. International Journal of Cancer. 2024. doi:10.1002/ijc.34980

BibTeX
@article{Ehret2024,
  author = {Ehret, Felix and Rueß, Daniel and Blanck, Oliver and Fichte, Susanne and Chatzikonstantinou, Georgios and Wolff, Robert and Mose, Lucas and Mose, Stephan and Fortmann, Thomas and Lehrke, Ralph and Turna, Menekse and Caglar, Hale Basak and Mortasawi, Farshin and Bleif, Martin and Krug, David and Ruge, Maximilian I and Fürweger, Christoph and Muacevic, Alexander},
  title = {Stereotactic radiosurgery and radiotherapy for brainstem metastases: An international multicenter analysis},
  journal = {International Journal of Cancer},
  year = {2024},
  doi = {10.1002/ijc.34980}
}
Kostenlos starten →